ID
45329
Description
Principal Investigator: Matthew Meyerson, MD, PhD, Dana Farber Cancer Institute, Boston MA MeSH: Solitary Fibrous Tumors https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000568 Solitary fibrous tumors (SFTs) are rare mesenchymal tumors that can be benign or malignant. In this study, we sequenced and analyzed the exomes of 17 SFT matched tumor and normal pairs. This study appertains to a large endeavor to characterize cancers as part of the Slim Initiative for Genomic Medicine in the Americas (SIGMA) project.
Lien
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000568
Mots-clés
Versions (2)
- 31/10/2022 31/10/2022 - Simon Heim
- 13/12/2022 13/12/2022 - Kristina Keller
Détendeur de droits
Matthew Meyerson, MD, PhD, Dana Farber Cancer Institute, Boston MA
Téléchargé le
31 de outubro de 2022
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000568 Genomic Sequencing of Solitary Fibrous Tumors
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject source, subject source ID, consent group, and affection status of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, sample ID, sample source, sample source ID, and sample use variable obtained from participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, age, sex, race, primary disease, and treatment received before surgery of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, primary tumor, metastasis, or transformed cell line, and samples obtained from tumor after some treatment and associated with participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject source, subject source ID, consent group, and affection status of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, sample ID, sample source, sample source ID, and sample use variable obtained from participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Subject ID, age, sex, race, primary disease, and treatment received before surgery of participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, primary tumor, metastasis, or transformed cell line, and samples obtained from tumor after some treatment and associated with participants with solitary fibrous tumors and involved in the "Genomic Sequencing of Solitary Fibrous Tumors" project.
C1266119 (UMLS CUI [1,2])
C5395609 (UMLS CUI [1,3])